** FUSION ** WICHTIG ** FUSION ** WICHTIG **
09.08.05 16:49
#1
Calibra21
** FUSION ** WICHTIG ** FUSION ** WICHTIG **
WKN: A0DPT3, US-Kürzel: NNNC
Nannaco, Inc. verkündete heute die Durchführung des Fusionsvertrags mit Premier Developer und Hersteller von Nutraceuticals.
http://www.nasdaq.com//aspxcontent/...cdtime=08%2F09%2F2005+10%3A00AM
Achtung: Aktie bereits 225 % im plus! Und trotzdem lohnt der Einstieg! Denn die Market-Cap beträgt trotz des Kursanstiegs gerade mal 1.54 k !
Wirklich ein Geschenk! 1,500 Tausend! Ich habe meinen Augen selbst nicht getraut. Aber auf der OTCBB Seite stehts.
Dieser Titel wird 1000% machen. Bin mir wirklich zu 99,99% sicher.
Nannaco, Inc. verkündete heute die Durchführung des Fusionsvertrags mit Premier Developer und Hersteller von Nutraceuticals.
http://www.nasdaq.com//aspxcontent/...cdtime=08%2F09%2F2005+10%3A00AM
Achtung: Aktie bereits 225 % im plus! Und trotzdem lohnt der Einstieg! Denn die Market-Cap beträgt trotz des Kursanstiegs gerade mal 1.54 k !
Wirklich ein Geschenk! 1,500 Tausend! Ich habe meinen Augen selbst nicht getraut. Aber auf der OTCBB Seite stehts.
Dieser Titel wird 1000% machen. Bin mir wirklich zu 99,99% sicher.
09.08.05 17:50
#4
Calibra21
die 0,002
dürften bald fallen.
Berlin:
Verkauf Orders
Limit Stücke
0,002 500.000
0,003 1.000.000
Berlin:
Verkauf Orders
Limit Stücke
0,002 500.000
0,003 1.000.000
09.08.05 18:07
#7
Kicky
reverse merger :Amenni hält dann 97% von NNNC
On July 21, 2005, Nannaco entered into an agreement to merge a wholly owned subsidiary of Registrant with and into Amenni, and to rename Registrant "Amenni Inc." (the "reverse merger"). The agreement provides that all of the shares of common stock of Amenni, issued and outstanding at the time the merger becomes effective under applicable state law (the "Effective Time"), will be converted into common stock of Registrant such that the current holders of Amenni common stock will hold 97% of all shares of Registrant's common stock outstanding immediately after the closing of this merger transaction. 08/09/2005 10:00AM - PrimeZone Media Network
auch um 16Uhr 15 war das schon kein guter Tip mehr,da hättste früher sein müssen
auch um 16Uhr 15 war das schon kein guter Tip mehr,da hättste früher sein müssen
09.08.05 18:30
#8
Calibra21
Typisch Kicky!
Warum erkennst du die Chance nicht? Bereits 4,4 Millionen Stücke in Berlin gehandelt!
Jetzt Ask wieder 0,002
Berliner Orderbuch:
Verkauf Orders
Limit Stücke
0,002 500.000
0,003 500.000
Jetzt Ask wieder 0,002
Berliner Orderbuch:
Verkauf Orders
Limit Stücke
0,002 500.000
0,003 500.000
09.08.05 22:04
#10
Calibra21
+350%
Kicky! Wo war dies ein schlechter Tip??? Kannst du mir das mal veraten?
10.08.05 16:09
#12
Calibra21
0,006
Kicky?? Noch da?? Ich habe soeben 500% realisiert! Innerhalb eines Tages. Schlechter Tip. Wenn du meinst...
10.08.05 18:54
#15
Calibra21
Danke!!
Bin jetzt zu 0,004 wieder rein! Mal schaun. Nochmal auf 0,006. Wären ja wieder 50 %
10.08.05 19:23
#16
gindants
hey calibra
hast ja noch raum nach oben: die kommen von 2100$!!!!!!!!! her LOL
11.08.05 18:10
#17
Brokersince1994
Wahnsinn *g*
Amenni, Inc., Merger Partner of Nannaco, Moves into $1 Billion Pain-Killer Marketplace
Thursday August 11, 11:07 am ET
GIG HARBOR, Wash. and FT. LAUDERDALE, Fla., Aug. 11, 2005 (PRIMEZONE) -- Amenni, Inc. (``Amenni''), merger partner of Nannaco, Inc. (OTC BB:NNNC.OB - News) (``Nannaco''), announced today that it has entered the over-the-counter (``OTC'') pain-killer marketplace. Amenni will begin trials of their innovative ibuprofen patch.
ADVERTISEMENT
Amenni believes that this new product will be of great benefit for those patients who have difficulty in taking pain-killers orally. Amenni's market research has indicated the Ibuprofen patch will fill a significant niche in the $1 billion + OTC pain-killer market.
Nannaco previously announced July 21, 2005 it entered into a Definitive Merger Agreement with Amenni. Amenni, with offices in Ft. Lauderdale, and facilities located in London (United Kingdom), Dubai (United Arab Emirates) and Zurich (Switzerland), develops and manufactures joint-care nutraceutical products for dogs and horses.
Amenni has initially distributed these product lines through a distribution agreement with an internationally recognized pharmaceutical firm. Revenues in the first 12 months from this agreement exceeded $1 million, and the first product was launched in 10 countries. Amenni anticipates a roll-out to the U.S. marketplace, as well as 14-19 additional countries, within the next 12 months.
For 2004, Amenni's combined revenues exceeded $3 million. Amenni anticipates generating more than $6 million in 2005.
Amenni has also initiated the launch of their highly innovative Sports Patch into the U.S. OTC market. Its primary active ingredients have been developed in conjunction with its highly successful research into Veterinary Science.
The Sports Patch is targeting the fast-growing Sports Healthcare market and has shown significant benefits to aid the recovery from a Sports injury. Joint and ligament injuries happen to all athletes. The Amenni Sports Patch applied immediately after injury helps with quicker recovery times. Currently there are no direct competitors in the marketplace.
Amenni is developing additional products for distribution by this and other distribution partners. Furthermore, Amenni continues to develop nutraceutical products aimed at the human (as well as animal) marketplace.
NOTE: Information contained in this press release, other than historical information, should be considered forward-looking in nature and is subject to various risks or uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or expected. Among the key factors that may have a direct bearing on the operating results, performance or financial condition are the company's ability to achieve and manage growth; the company's ability to attract and retain qualified personnel; the company's ability to secure necessary financing; potential litigation by shareholders and/or former or current advisors against the company; the company's success in securing third-party commitments, production agreements and/or licensing contracts; the company's ability to comply with federal, state and local government regulations and/or unforeseen changes in federal or and government regulation; and the company's ability to develop new services; and other factors discussed in Nannaco's filings with the Securities and Exchange Commission.
Contact:
Nannaco, Inc.
Steve Careaga
253-853-3632
or
Send correspondence to:
4916 Point Fosdick Dr., Suite 102
Gig Harbor, WA 98335
--------------------------------------------------
Source: Nannaco, Inc
Gruß
C.O
Thursday August 11, 11:07 am ET
GIG HARBOR, Wash. and FT. LAUDERDALE, Fla., Aug. 11, 2005 (PRIMEZONE) -- Amenni, Inc. (``Amenni''), merger partner of Nannaco, Inc. (OTC BB:NNNC.OB - News) (``Nannaco''), announced today that it has entered the over-the-counter (``OTC'') pain-killer marketplace. Amenni will begin trials of their innovative ibuprofen patch.
ADVERTISEMENT
Amenni believes that this new product will be of great benefit for those patients who have difficulty in taking pain-killers orally. Amenni's market research has indicated the Ibuprofen patch will fill a significant niche in the $1 billion + OTC pain-killer market.
Nannaco previously announced July 21, 2005 it entered into a Definitive Merger Agreement with Amenni. Amenni, with offices in Ft. Lauderdale, and facilities located in London (United Kingdom), Dubai (United Arab Emirates) and Zurich (Switzerland), develops and manufactures joint-care nutraceutical products for dogs and horses.
Amenni has initially distributed these product lines through a distribution agreement with an internationally recognized pharmaceutical firm. Revenues in the first 12 months from this agreement exceeded $1 million, and the first product was launched in 10 countries. Amenni anticipates a roll-out to the U.S. marketplace, as well as 14-19 additional countries, within the next 12 months.
For 2004, Amenni's combined revenues exceeded $3 million. Amenni anticipates generating more than $6 million in 2005.
Amenni has also initiated the launch of their highly innovative Sports Patch into the U.S. OTC market. Its primary active ingredients have been developed in conjunction with its highly successful research into Veterinary Science.
The Sports Patch is targeting the fast-growing Sports Healthcare market and has shown significant benefits to aid the recovery from a Sports injury. Joint and ligament injuries happen to all athletes. The Amenni Sports Patch applied immediately after injury helps with quicker recovery times. Currently there are no direct competitors in the marketplace.
Amenni is developing additional products for distribution by this and other distribution partners. Furthermore, Amenni continues to develop nutraceutical products aimed at the human (as well as animal) marketplace.
NOTE: Information contained in this press release, other than historical information, should be considered forward-looking in nature and is subject to various risks or uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or expected. Among the key factors that may have a direct bearing on the operating results, performance or financial condition are the company's ability to achieve and manage growth; the company's ability to attract and retain qualified personnel; the company's ability to secure necessary financing; potential litigation by shareholders and/or former or current advisors against the company; the company's success in securing third-party commitments, production agreements and/or licensing contracts; the company's ability to comply with federal, state and local government regulations and/or unforeseen changes in federal or and government regulation; and the company's ability to develop new services; and other factors discussed in Nannaco's filings with the Securities and Exchange Commission.
Contact:
Nannaco, Inc.
Steve Careaga
253-853-3632
or
Send correspondence to:
4916 Point Fosdick Dr., Suite 102
Gig Harbor, WA 98335
--------------------------------------------------
Source: Nannaco, Inc
Gruß
C.O
11.08.05 18:23
#18
RoulettProfi
Wahnsinnnnnnn,kein halten!
USA -RT:0,0063 Plus10,5% -200.000.000Mill.Gehandelt
1Cent müßte heute noch drin sein,jep
11.08.05 18:26
#19
Brokersince1994
Ich bin schwer am überlegen ,ob Ich
noch reichlich rein soll , was meint Ihr ?
Gruß
C.O
Gruß
C.O
17.08.05 23:03
#20
Dr.Sorius
Ja
nach einschlägigen Top-News knallt der Furz und die Knospen im Garten spriessen,und der Herr sprach, es werde Frühling an einem Tag im August der der vorletzte Freitag im August des Jahres Anno 2005 sein soll.AMEN

